-
VEDOKIDS study: Predicting response to Vedolizumab in Pediatric Inflammatory Bowel Diseases including drug levels: a multi-center prospective Pan- European cohort study (P-ECCO and ESPGHAN)
Vedolizumab (VDZ) is a humanized immunoglobulin G1 monoclonal antibody acting against a4ß7 integrin which modulates lymphocyte trafficking in the gut. Results from the adult GEMINI-1 ...Phase N/A
Non-Interventional
-
NYU Langone IBD Biorepository
We are building a biorepository of samples from patients who have Inflammatory Bowel Diseases and controls. Samples will include blood, stool, and mucosal biopsy samples.Phase N/A Non-Interventional
-
Role of the oral cavity in inflammatory bowel disease
The purpose of this investigation is to create a study bank of clinical data, peripheral blood, oral and gut microbiomes, and mucosal pinch biopsy specimens ...Phase N/A Non-Interventional
-
Proactive infliximab optimization using a pharmacokinetic dashboard versus standard of care in patients with Crohn s disease: The OPTIMIZE Trial
This is a randomized, controlled, multicenter, open-label study. All eligible subjects will be randomly assigned in a 1:1 ratio to receive either IFX monotherapy ...Phase N/A
Interventional
-
Gastrointestinal tract colonization and Staphylococcus aureus associated skin diseases
Our ultimate goal is to improve our understanding of the complex interplay of host, pathogen, and microbiome in Staphylococcus aureus-associated skin diseases. These diseases include ...Phase N/A Non-Interventional
